GLP 1
Survodutide Latest Research: New Indications, Trials & What’s Coming
Survodutide is among the most-watched investigational drugs for combined obesity and liver disease.
Survodutide Who Should (and Shouldn’t) Take It: Eligibility & Contraindications
Introduction Survodutide is in Phase 3 development with two primary indications under investigation: obesity (SYNCHRONIZE-1 and SYNCHRONIZE-2 trials) and MASH liver disease (LIVERAGE program)….
Survodutide Drug Interactions: What You Can and Can’t Take with It
Survodutide isn’t on the market yet, so no FDA-issued interaction label exists.
Survodutide Dosing Guide: Schedule, Titration & What to Expect Each Week
Survodutide dosing is set by the Phase 2 and ongoing Phase 3 protocols from Boehringer Ingelheim and Zealand Pharma.
Survodutide Cost Breakdown: Brand, Compounded, Insurance & Savings Options
Survodutide is still in Phase 3 development, so no commercial pricing exists yet.
Supplements to Take (and Avoid) on GLP-1 Medications
Rapid weight loss creates real nutrient gaps.
Strength Training on GLP-1: The #1 Way to Prevent Muscle Loss
When the STEP 1 trial (Wilding et al.
Stockpiling GLP-1: Why It’s Counterproductive
When supply gets tight, the natural instinct is to grab extra. Patients who can fill three months at once try to fill six.
Starting GLP-1 Now vs Waiting: The Cost of Delay
The decision to start a GLP-1 isn’t urgent in the same way that treating a heart attack is urgent. Patients can wait months or years to decide.
